Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma.

about

New developments in the pathology of malignant lymphoma. A review of the literature published from September-August 2017.Survival associated alternative splicing events in diffuse large B-cell lymphoma

P2860

Q47162060-E600523D-A843-4241-A198-D500EB93A7A7 Q58776059-551725D3-8ACA-4393-81C2-0CB4717AD009

P2860

Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma.

Item

http://www.wikidata.org/entity/Q41177221

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Alternative splicing discrimin ...... diffuse large B-cell lymphoma.

@en

type

Item

label

Alternative splicing discrimin ...... diffuse large B-cell lymphoma.

@en

prefLabel

Alternative splicing discrimin ...... diffuse large B-cell lymphoma.

@en

P1476

Alternative splicing discrimin ...... diffuse large B-cell lymphoma

@en

P2093

A Cervera

http://www.w3.org/2001/XMLSchema#string

H Holte

http://www.w3.org/2001/XMLSchema#string

M Taskinen

http://www.w3.org/2001/XMLSchema#string

M-L Karjalainen-Lindsberg

http://www.w3.org/2001/XMLSchema#string

P2860

PTPROt: an alternatively spliced and developmentally regulated B-lymphoid phosphatase that promotes G0/G1 arrest

Mammalian APH-1 interacts with presenilin and nicastrin and is required for intramembrane proteolysis of amyloid-beta precursor protein and Notch

InterProScan 5: genome-scale protein function classification

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations

The genetic landscape of diffuse large B-cell lymphoma

P2888

bcj.2017.71

P304

e596

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BCJ.2017.71

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091339167

http://www.w3.org/2001/XMLSchema#string

P698

28841210

http://www.w3.org/2001/XMLSchema#string

P932

5596382

http://www.w3.org/2001/XMLSchema#string

Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma.

about

P2860

P2860

Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932